Almac cancer research funding boost

Almac has invested £13 million into two cancer research ventures, with £7 million to be spent in Northern Ireland.

The pharmaceutical company, in a partnership with Queen’s University, are set to undertake research into the clinical performance of a drug developed within Northern Ireland. There will also be a project that has the intention of setting up a drug discovery unit in Queen’s Cancer research and Cell Biology centre at Belfast City Hospital.

Almac  is an international organisation providing a comprehensive range of services from research through pharmaceutical development to commercialisation of product. For more information on Almac’s services and the company itself, click here.

To search through our current science vacancies, click here.

Posted in: Industry News, Mobile News, News
A picture of Almac's logo